ENDOSYME OBI Trademark

Trademark Overview


On Monday, November 27, 2023, a trademark application was filed for ENDOSYME OBI with the United States Patent and Trademark Office. The USPTO has given the ENDOSYME OBI trademark a serial number of 98287135. The federal status of this trademark filing is NOTICE OF ALLOWANCE - ISSUED as of Tuesday, October 1, 2024. This trademark is owned by OBI PHARMA, INC.. The ENDOSYME OBI trademark is filed in the Pharmaceutical Products category with the following description:

Immunostimulants; Vaccines; Adjuvants for medical purposes; Anti-cancer preparations; Biological preparations for the treatment of cancer; Chemical preparations for pharmaceutical or medical purposes, namely, for cancer to be prevented or treated; Chemical reagents for medical or veterinary purposes; Enzyme preparations for medical purposes; Enzymes for medical purposes; Ferments for pharmaceutical purposes; Hormones for medical purposes; Medicinal preparations for the treatment of infectious diseases and for use in oncology; Pharmaceutical preparations for suppressing tumors; Pharmaceutical preparations for the treatment and prevention of cancer; Pharmaceutical preparations for use in chemotherapy; Pharmaceutical products for the prevention and treatment of cancer; Pharmaceutical products for the treatment of cancer; Pharmaceutical products for the treatment of viral and infectious diseases, for the treatment of cancer; Preparations of microorganisms for medical purposes; Tumor suppre...
endosyme obi

General Information


Serial Number98287135
Word MarkENDOSYME OBI
Filing DateMonday, November 27, 2023
Status688 - NOTICE OF ALLOWANCE - ISSUED
Status DateTuesday, October 1, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, August 6, 2024

Trademark Statements


Description of MarkThe mark consists of the black stylized wording "EndoSyme" and the teal stylized wording "OBI"with a curved teal line below "OBI".
Goods and ServicesImmunostimulants; Vaccines; Adjuvants for medical purposes; Anti-cancer preparations; Biological preparations for the treatment of cancer; Chemical preparations for pharmaceutical or medical purposes, namely, for cancer to be prevented or treated; Chemical reagents for medical or veterinary purposes; Enzyme preparations for medical purposes; Enzymes for medical purposes; Ferments for pharmaceutical purposes; Hormones for medical purposes; Medicinal preparations for the treatment of infectious diseases and for use in oncology; Pharmaceutical preparations for suppressing tumors; Pharmaceutical preparations for the treatment and prevention of cancer; Pharmaceutical preparations for use in chemotherapy; Pharmaceutical products for the prevention and treatment of cancer; Pharmaceutical products for the treatment of cancer; Pharmaceutical products for the treatment of viral and infectious diseases, for the treatment of cancer; Preparations of microorganisms for medical purposes; Tumor suppressing agents
Indication of Colors claimedThe color(s) black and teal is/are claimed as a feature of the mark.

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, January 18, 2024
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameOBI PHARMA, INC.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressTaipei City 115011
TW

Party NameOBI PHARMA, INC.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressTaipei City 115011
TW

Trademark Events


Event DateEvent Description
Friday, December 1, 2023NEW APPLICATION ENTERED
Tuesday, March 26, 2024APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, March 26, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, June 27, 2024EXAMINERS AMENDMENT -WRITTEN
Thursday, June 27, 2024NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Thursday, June 27, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, June 27, 2024EXAMINERS AMENDMENT E-MAILED
Thursday, January 18, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, January 19, 2024NOTICE OF DESIGN SEARCH CODE E-MAILED
Tuesday, March 26, 2024TEAS CHANGE OF OWNER ADDRESS RECEIVED
Wednesday, June 26, 2024ASSIGNED TO EXAMINER
Thursday, June 27, 2024EXAMINER'S AMENDMENT ENTERED
Wednesday, July 17, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, August 6, 2024PUBLISHED FOR OPPOSITION
Tuesday, August 6, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 1, 2024NOA E-MAILED - SOU REQUIRED FROM APPLICANT